Global RNA Targeting Small Molecules Therapeutics Market Report 2024

RNA Targeting Small Molecules Therapeutics Global Market Report 2024 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings), By Therapeutic Indication (Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications), By Application (Drug Discovery, Oncology Research, Disease Identification), By End User (Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
RNA Targeting Small Molecules Therapeutics Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

RNA Targeting Small Molecules Therapeutics Market Definition And Segments

RNA-targeting small molecule therapeutics refers to small molecule therapeutics that precisely interact with RNA molecules to modify their function or stability. These treatments treat diseases by employing small-molecule drugs to target disease-causing RNA molecules.

The main offerings of RNA targeting small molecule therapeutics are mRNA (messenger ribonucleic acid) translation modulators, RNA (ribonucleic acid) splicing modification, direct RNA (ribonucleic acid) targeting, and others. mRNA translation modulators are substances or factors that influence the process of protein synthesis by altering the efficiency or rate of mRNA translation. These are indicated for the treatment of lung fibrosis, cancer, neurodegenerative diseases, autoimmune, inflammatory, and others, with applications including drug discovery, oncology research, and disease identification performed by hospitals, research laboratories, pharmaceutical and biotechnology companies, and others.

The RNA targeting small molecules therapeutics market covered in this report is segmented –

1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings

2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications

3) By Application: Drug Discovery, Oncology Research, Disease Identification

4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users

The RNA targeting small molecules therapeutics market size has grown exponentially in recent years. It will grow from $1.06 billion in 2023 to $1.45 billion in 2024 at a compound annual growth rate (CAGR) of 37.0%. The growth in the historic period can be attributed to drug discovery and development, rising prevalence of RNA-related diseases, government and private funding, pharmaceutical industry interest, RNA therapeutics success stories.

The RNA targeting small molecules therapeutics market size is expected to see exponential growth in the next few years. It will grow to $5.09 billion in 2028 at a compound annual growth rate (CAGR) of 36.9%. The growth in the forecast period can be attributed to precision medicine and personalized therapies, rise in RNA biomarker identification, expanding RNA target spectrum, increasing funding and investments, application in rare diseases. Major trends in the forecast period include advancements in screening technologies, antisense oligonucleotides dominance, small molecule RNA binders, RNA therapeutics in neurological disorders, gene editing with crispr-cas9.

Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market

The increasing number of cancer cases is expected to propel the growth of the RNA-targeting small molecule therapeutics market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. Cancer is treated with RNA-targeting small molecules created and investigated to target RNA molecules associated with cancer selectively. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. Therefore, the increasing number of cancer cases is driving the growth of the RNA-targeting small molecule therapeutics market.

Growing Genetic Disorder Incidence Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market

The rising incidence of genetic disorders is expected to boost the growth of the RNA-targeting small-molecule therapeutics market going forward. Genetic disorders are conditions caused by abnormalities or mutations in an individual's genetic material, such as DNA or chromosomes. RNA-targeting small-molecule therapeutics are an exciting emerging field with immense potential for treating genetic disorders. Some genetic disorders involve toxic expansions of repeated RNA sequences. Small molecules can stabilize or destabilize these expansions, potentially mitigating their harmful effects. For instance, in June 2023, according to a report published by the Lancet, a UK-based medical journal, globally, the population of individuals with sickle cell disease witnessed a 41.4% surge to reach 7.74 million in 2021, with a projected 34,400 cause-specific deaths and a significantly higher total mortality burden of 376,000. Among children under 5 years, there were 81,100 deaths, elevating the overall sickle cell disease mortality ranking to 12th globally. Therefore, the rising incidence of genetic disorders is driving the growth of the RNA-targeting small-molecule therapeutic market.

The Growing Significance Of RNA-Targeting Small Molecule Therapeutics In Addressing Rising Global Infectious Diseases

The rising infectious diseases worldwide are expected to boost the growth of the RNA-targeting small molecule therapeutics market. Infectious diseases refer to disorders caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. RNA-targeting small molecules is emerging as a promising new approach to combatting infectious diseases. These small molecules, typically less than 500 daltons, bind to specific structures within RNA molecules, thereby disrupting their function and hindering the pathogen's replication or virulence. For instance, in December 2022, according to the Office for National Statistics, a UK-based recognized national statistics institute, the infection rate climbed for people aged 35 to 69 years and increased for those in school years 12 to 24 years in England. The total hospital admission rate for patients with confirmed COVID-19 in England increased to 9.56 per 100,000 individuals. The admission rate to intensive care units (ICUs) and high dependency units (HDUs) climbed to 0.29 per 100,000 inhabitants. Therefore, the rising infectious diseases worldwide are driving the growth of the RNA-targeting small molecule therapeutics market.

Major companies operating in the RNA targeting small molecules therapeutics market report are F. Hoffmann-La Roche Ltd., Bayer AG, Sanofi S.A., AstraZeneca PLC, Eli Lilly and Company, Amgen Inc., Janssen Pharmaceuticals, Celgene Corporation, Vertex Pharmaceuticals, Servier laboratories, Genentech Inc., PTC Therapeutics Inc., Arrakis Therapeutics, Anima Biotech Inc., Skyhawk Therapeutics Inc., Remix Therapeutics, Abivax SA, 858 Therapeutics, Eloxx Pharmaceuticals Inc., STORM Therapeutics Ltd., Accent Therapeutics Inc., eFFECTOR Therapeutics Inc., EPICS Therapeutics, Expansion Therapeutics Inc., Inspirna Inc., MiNA Therapeutics Ltd., Ribometrix Inc., AC Immune SA, Redona Therapeutics.

Strategic Partnerships Drive Innovation In The RNA-Targeting Small Molecule Therapeutics Market

Strategic partnerships are a key trend gaining popularity in the RNA-targeting small molecule therapeutics market. Major companies operating in the RNA-targeting small molecule therapeutics market are undergoing partnerships to develop a new relationship in which two or more organizations develop innovative products. For instance, in June 2022, Otsuka Pharmaceutical Co. Ltd., a Japan-based pharmaceutical manufacturing company, collaborated with xFOREST Therapeutics Co. Ltd., a Japan-based developer of drug discovery platforms. With this partnership, xFOREST will offer Otsuka with its Forest technology to advance systemic small-molecule drug discovery research focusing on RNA structures. Furthermore, in March 2021, Evotec SE, a Germany-based drug discovery and development company, entered a strategic alliance with Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company. Both companies aim to discover and develop RNA-targeting small molecules with this alliance.

Ribometrix And Genentech Collaborate On Advancing RNA-Targeted Therapeutic Small Molecules

In January 2021, Ribometrix Inc., a US-based drug discovery company, collaborated with Genentech Inc. to find and create RNA-targeted therapeutic small molecules. In this collaboration, Genentech and Ribometrix will develop programs, development, and commercialization within Genentech's purview to see and improve small-molecule drugs that modify RNA function by focusing on three-dimensional (3D) RNA structures. Genentech Inc. is a US-based biotechnology research company.

North America was the largest region in the RNA targeting small molecules therapeutics market in 2023. The regions covered in the RNA targeting small molecules therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the RNA targeting small molecules therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The RNA-targeting small molecule therapeutics market consists of sales of nusinersen, inotersen, givosiran, and patisiran. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The RNA targeting small molecules therapeutics research report is one of a series of new reports from The Business Research Company that provides RNA targeting small molecules therapeutics market statistics, including the RNA targeting small molecules therapeutics industry's global market size, regional shares, competitors with RNA targeting small molecules therapeutics market share, detailed RNA targeting small molecules therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the RNA targeting small molecules therapeutics industry. This RNA-targeting small molecules therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

RNA Targeting Small Molecules Therapeutics Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.45 billion
Revenue Forecast In 2033 $5.09 billion
Growth Rate CAGR of 36.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Offering: mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Targeting, Other Offerings
2) By Therapeutic Indication: Lung Fibrosis, Cancer, Neurodegenerative Diseases, Autoimmune, Inflammatory, Other Therapeutic Indications
3) By Application: Drug Discovery, Oncology Research, Disease Identification
4) By End User: Hospitals, Research Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled F. Hoffmann-La Roche Ltd.; Bayer AG; Sanofi S.A.; AstraZeneca plc; Eli Lilly and Company; Amgen Inc.; Janssen Pharmaceuticals; Celgene Corporation; Vertex Pharmaceuticals; Servier laboratories; Genentech Inc.; PTC Therapeutics Inc.; Arrakis Therapeutics; Anima Biotech Inc.; Skyhawk Therapeutics Inc.; Remix Therapeutics; Abivax SA; 858 Therapeutics; Eloxx Pharmaceuticals Inc.; STORM Therapeutics Ltd.; Accent Therapeutics Inc.; eFFECTOR Therapeutics Inc.; EPICS Therapeutics; Expansion Therapeutics Inc.; Inspirna Inc.; MiNA Therapeutics Ltd.; Ribometrix Inc.; AC Immune SA; Redona Therapeutics.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. RNA Targeting Small Molecules Therapeutics Market Characteristics

    3. RNA Targeting Small Molecules Therapeutics Market Trends And Strategies

    4. RNA Targeting Small Molecules Therapeutics Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global RNA Targeting Small Molecules Therapeutics Market Size and Growth

    5.1. Global RNA Targeting Small Molecules Therapeutics Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global RNA Targeting Small Molecules Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global RNA Targeting Small Molecules Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. RNA Targeting Small Molecules Therapeutics Market Segmentation

    6.1. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    mRNA (Messenger Ribonucleic Acid) Translation Modulators

    RNA (Ribonucleic Acid) Splicing Modification

    Direct RNA (Ribonucleic Acid) Targeting

    Other Offerings

    6.2. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Lung Fibrosis

    Cancer

    Neurodegenerative Diseases

    Autoimmune

    Inflammatory

    Other Therapeutic Indications

    6.3. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Drug Discovery

    Oncology Research

    Disease Identification

    6.4. Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Research Laboratories

    Pharmaceutical And Biotechnology Companies

    Other End-Users

    7. RNA Targeting Small Molecules Therapeutics Market Regional And Country Analysis

    7.1. Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market

    8.1. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China RNA Targeting Small Molecules Therapeutics Market

    9.1. China RNA Targeting Small Molecules Therapeutics Market Overview

    9.2. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India RNA Targeting Small Molecules Therapeutics Market

    10.1. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan RNA Targeting Small Molecules Therapeutics Market

    11.1. Japan RNA Targeting Small Molecules Therapeutics Market Overview

    11.2. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia RNA Targeting Small Molecules Therapeutics Market

    12.1. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia RNA Targeting Small Molecules Therapeutics Market

    13.1. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea RNA Targeting Small Molecules Therapeutics Market

    14.1. South Korea RNA Targeting Small Molecules Therapeutics Market Overview

    14.2. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe RNA Targeting Small Molecules Therapeutics Market

    15.1. Western Europe RNA Targeting Small Molecules Therapeutics Market Overview

    15.2. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK RNA Targeting Small Molecules Therapeutics Market

    16.1. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany RNA Targeting Small Molecules Therapeutics Market

    17.1. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France RNA Targeting Small Molecules Therapeutics Market

    18.5. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy RNA Targeting Small Molecules Therapeutics Market

    19.9. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain RNA Targeting Small Molecules Therapeutics Market

    20.13. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe RNA Targeting Small Molecules Therapeutics Market

    21.1. Eastern Europe RNA Targeting Small Molecules Therapeutics Market Overview

    21.2. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia RNA Targeting Small Molecules Therapeutics Market

    22.1. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America RNA Targeting Small Molecules Therapeutics Market

    23.1. North America RNA Targeting Small Molecules Therapeutics Market Overview

    23.2. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA RNA Targeting Small Molecules Therapeutics Market

    24.1. USA RNA Targeting Small Molecules Therapeutics Market Overview

    24.2. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada RNA Targeting Small Molecules Therapeutics Market

    25.1. Canada RNA Targeting Small Molecules Therapeutics Market Overview

    25.2. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America RNA Targeting Small Molecules Therapeutics Market

    26.1. South America RNA Targeting Small Molecules Therapeutics Market Overview

    26.2. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil RNA Targeting Small Molecules Therapeutics Market

    27.1. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East RNA Targeting Small Molecules Therapeutics Market

    28.1. Middle East RNA Targeting Small Molecules Therapeutics Market Overview

    28.2. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa RNA Targeting Small Molecules Therapeutics Market

    29.1. Africa RNA Targeting Small Molecules Therapeutics Market Overview

    29.2. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape And Company Profiles

    30.1. RNA Targeting Small Molecules Therapeutics Market Competitive Landscape

    30.2. RNA Targeting Small Molecules Therapeutics Market Company Profiles

    30.2.1. F. Hoffmann-La Roche Ltd.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bayer AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sanofi S.A.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AstraZeneca plc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Eli Lilly and Company

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies

    31.1. Amgen Inc.

    31.2. Janssen Pharmaceuticals

    31.3. Celgene Corporation

    31.4. Vertex Pharmaceuticals

    31.5. Servier laboratories

    31.6. Genentech Inc.

    31.7. PTC Therapeutics Inc.

    31.8. Arrakis Therapeutics

    31.9. Anima Biotech Inc.

    31.10. Skyhawk Therapeutics Inc.

    31.11. Remix Therapeutics

    31.12. Abivax SA

    31.13. 858 Therapeutics

    31.14. Eloxx Pharmaceuticals Inc.

    31.15. STORM Therapeutics Ltd.

    32. Global RNA Targeting Small Molecules Therapeutics Market Competitive Benchmarking

    33. Global RNA Targeting Small Molecules Therapeutics Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The RNA Targeting Small Molecules Therapeutics Market

    35. RNA Targeting Small Molecules Therapeutics Market Future Outlook and Potential Analysis

    35.1 RNA Targeting Small Molecules Therapeutics Market In 2028 - Countries Offering Most New Opportunities

    35.2 RNA Targeting Small Molecules Therapeutics Market In 2028 - Segments Offering Most New Opportunities

    35.3 RNA Targeting Small Molecules Therapeutics Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 76: Bayer AG Financial Performance
  • Table 77: Sanofi S.A. Financial Performance
  • Table 78: AstraZeneca plc Financial Performance
  • Table 79: Eli Lilly and Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global RNA Targeting Small Molecules Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global RNA Targeting Small Molecules Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, RNA Targeting Small Molecules Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: Sanofi S.A. Financial Performance
  • Figure 78: AstraZeneca plc Financial Performance
  • Figure 79: Eli Lilly and Company Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report